---
title: "基于单细胞和整体RNA测序的氧化应激反应生物标志物的卵巢癌研究（文章复现）1.文章概述"
date: 2024-10-27T23:43:40Z
draft: ["false"]
tags: [
  "fetched",
  "R 学习践行者"
]
categories: ["Acdemic"]
---
基于单细胞和整体RNA测序的氧化应激反应生物标志物的卵巢癌研究（文章复现）1.文章概述 by R 学习践行者
------
<div><p><img data-galleryid="" data-imgfileid="100002558" data-ratio="0.27918170878459686" data-s="300,640" data-type="png" data-w="831" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz5GWnqaSEJGBuJaj8WEs8lCN8icQSKic4Oo5K9mpLibg34jhL0FW6qzicmQ/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz5GWnqaSEJGBuJaj8WEs8lCN8icQSKic4Oo5K9mpLibg34jhL0FW6qzicmQ/640?wx_fmt=png&amp;from=appmsg"></p><p><span><span>背景</span><span><p></p></span></span></p><p><span><span> 由于</span><span><span>卵巢癌（</span>OV<span>）的发生和发展受氧化应激（</span><span>OS</span><span>）副产物增加和缺乏抗氧化应激修复系统的显著影响。因此，有必要探索与</span><span>OV</span><span>相关的</span><span>OS</span><span>标志物，这有助于预测患者的预后和免疫治疗反应</span></span><span>，该研究基于此目的开展了这项研究。<p></p></span></span></p><p><span>该研究的整体分析思路如下所示：</span></p><p><img data-galleryid="" data-imgfileid="100002559" data-ratio="0.5879518072289157" data-s="300,640" data-type="png" data-w="830" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz1GiasL5cXYZDxRYUqd8rQiaJC2HQQuKc9LUDofJu79hOztQ4iamCFcz2A/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz1GiasL5cXYZDxRYUqd8rQiaJC2HQQuKc9LUDofJu79hOztQ4iamCFcz2A/640?wx_fmt=png&amp;from=appmsg"></p><p><span><span>  首先</span><span><span>从基因表达综合（</span>GEO<span>）数据库中检索单细胞</span><span>RNA</span><span>测序（</span><span>scRNA-seq</span><span>）数据集</span><span>GSE146026</span><span>，并从</span><span>TCGA</span><span>和</span><span>GTEx</span><span>数据库中获取整体</span><span>RNA</span><span>测序数据。</span></span><span>然后</span><span><span>使用</span>Seurat R<span>包和</span><span>SingleR</span><span>包分析</span><span>scRNA-seq</span><span>数据，并基于</span><span>ROS</span><span>标志物识别</span><span>OS</span><span>反应相关的簇。</span></span><span>接着</span><span><span>使用</span>"limma" R<span>包识别正常和卵巢样本之间的差异表达基因（</span><span>DEGs</span><span>）。</span></span><span>并</span><span><span>使用最小绝对收缩和选择算子（</span>LASSO<span>）回归分析构建风险模型。</span></span><span>最后</span><span><span>利用</span>CIBERSORT<span>算法、</span><span>"maftools"</span><span>和</span><span>"pRRophetic" R</span><span>包分别分析模型的免疫细胞浸润、基因组突变和药物敏感性。</span><p></p></span></span></p><p><span>结果<p></p></span></p><p><span><span><span>  基于</span>scRNA-seq<span>数据，我们识别了</span><span>12</span><span>个簇；</span><span>OS</span><span>反应相关基因对簇</span><span>12</span><span>具有最强的特异性。从</span><span>2928</span><span>个</span><span>DEGs</span><span>中共识别出</span><span>151</span><span>个与</span><span>OS</span><span>反应显著相关的基因</span></span><span>；</span><span><span>最后，使用</span>9<span>个预后基因构建了风险评分（</span><span>RS</span><span>）模型</span></span><span>。</span></span></p><p><img data-galleryid="" data-imgfileid="100002560" data-ratio="1.0126582278481013" data-s="300,640" data-type="png" data-w="237" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz8e6olSfuzcnGHpsLrFzhHp0UWicguD1MPfdQ0amXibeAA1ujd54W4spQ/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz8e6olSfuzcnGHpsLrFzhHp0UWicguD1MPfdQ0amXibeAA1ujd54W4spQ/640?wx_fmt=png&amp;from=appmsg"></p><p><span><span>  图</span><span>1.9</span><span>个预后基因的</span><span>LASSO</span><span>回归系数</span><p></p></span></p><p><span><span><span>风险评分模型是</span>OV<span>的独立预后因子</span></span><span>；如下图所示。</span></span></p><p><img data-galleryid="" data-imgfileid="100002561" data-ratio="0.34949494949494947" data-s="300,640" data-type="png" data-w="495" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzzcshFJSJGGMcgTmsogCRTiaftrdw4kO10xusdeQdicic857JicKSABCPsw/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzzcshFJSJGGMcgTmsogCRTiaftrdw4kO10xusdeQdicic857JicKSABCPsw/640?wx_fmt=png&amp;from=appmsg"></p><p><span><span><span>  图</span><span>2.</span><span>高风险组和低风险组患者的生存曲线</span></span><span><p></p></span></span></p><p><span><span> 对高危组和低危组患者中突变频率最高的前</span><span>20</span><span>个基因进行了分析，并绘制了瀑布图。结果揭示了高危组和低危组患者的基因突变频率存在差异（下图</span>）<p></p></span></p><p><img data-galleryid="" data-imgfileid="100002562" data-ratio="0.7828418230563002" data-s="300,640" data-type="png" data-w="373" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzULzvJOgs44MIQNkdItaiawn0jRg3WjXJuibcpIcDL9KFbUXpKglwke4Q/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzULzvJOgs44MIQNkdItaiawn0jRg3WjXJuibcpIcDL9KFbUXpKglwke4Q/640?wx_fmt=png&amp;from=appmsg"></p><p><img data-galleryid="" data-imgfileid="100002563" data-ratio="0.8064516129032258" data-s="300,640" data-type="png" data-w="372" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz7r3uJPAR5iaHYSR2Q8JOsVPEWpJh2qicOpwfibabTqzdqia0xaDVBASM4Q/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNz7r3uJPAR5iaHYSR2Q8JOsVPEWpJh2qicOpwfibabTqzdqia0xaDVBASM4Q/640?wx_fmt=png&amp;from=appmsg"><span></span></p><p><span><span>     TME</span><span>中的免疫细胞浸润影响癌症的发生和发展。因此，</span>文章<span>利用</span> <span>CIBERSORT </span><span>算法探讨高危组和低危组患者 </span><span>TME </span><span>的差异</span>，<span>CIBERSORT </span><span>用于估计 </span><span>OV </span><span>中浸润的 </span><span>22 </span><span>种免疫细胞的比例</span>；分析显示，高危组和低危组患者的免疫细胞浸润肿瘤的比例存在显著差异。如下图所示。<p></p></span></p><p><img data-galleryid="" data-imgfileid="100002564" data-ratio="0.5224312590448625" data-s="300,640" data-type="png" data-w="691" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzPziby7hibPU434j5WhOIuRkQBOyKibxXuPqygqzCdfyYZ4HtVAib0Nwsqw/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzPziby7hibPU434j5WhOIuRkQBOyKibxXuPqygqzCdfyYZ4HtVAib0Nwsqw/640?wx_fmt=png&amp;from=appmsg"></p><p><span>  为了确定模型是否可以预测免疫治疗反应，比较高危组和低危组样本中免疫应答样本（完全应答（<span>CR</span>）<span>+</span>部分应答（<span>PR</span>））和非免疫应答样本（疾病稳定（<span>SD</span>）<span>+</span>疾病进展（<span>PD</span>））的分布差异使用累积分布图（图左）。与高风险组的患者相比，低风险组的患者对免疫治疗的反应更好。此外，<span>SD/PD</span>组患者的<span>RS</span>明显高于<span>CR</span>组患者（图右），表明低风险组患者对免疫治疗有更好的反应。</span></p><p><img data-galleryid="" data-imgfileid="100002565" data-ratio="1.6216216216216217" data-s="300,640" data-type="png" data-w="148" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzaNicF9fUHGuzILBneiaDhC7aaoVTicaT6J5CnAGl3icszkTJ54DRNqDcwQ/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzaNicF9fUHGuzILBneiaDhC7aaoVTicaT6J5CnAGl3icszkTJ54DRNqDcwQ/640?wx_fmt=png&amp;from=appmsg"></p><p><img data-galleryid="" data-imgfileid="100002566" data-ratio="0.9541666666666667" data-s="300,640" data-type="png" data-w="240" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzOGbGKlLIOGRm0eED5GgB36oVhCCmZRxfP7FzX45UmSCVpNGj08bIgQ/640?wx_fmt=png&amp;from=appmsg" src="https://mmbiz.qpic.cn/sz_mmbiz_png/IGjxEGEQ50n21enpnowjlra0e4zLytNzOGbGKlLIOGRm0eED5GgB36oVhCCmZRxfP7FzX45UmSCVpNGj08bIgQ/640?wx_fmt=png&amp;from=appmsg"></p><p><span>  综上所述，该文章<span>利用单细胞和整体</span>RNA测序数据创建了一个风险评分模型。用于构建该模型的基因基于与氧化应激反应及途径相关的基因与卵巢癌中氧化应激相关基因的交集。这个由九个基因构成的特征预后模型可以用于预测卵巢癌患者的预后和免疫反应。<p></p></span></p><p><span>  后面几章将复现该文章的单细胞分析部分，其他部分的分析内容之前已有展示就不继续展示。<p></p></span></p><p><span><span>原文：Oxidative medicine and cellular longevity, 2023, 1261039.</span><p></p></span></p><p><br></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/VUEs-cP0hjGJnR6aW1WcVw",target="_blank" rel="noopener noreferrer">原文链接</a>
